Hypocalcemia in Blood Transfusions

Primary Mechanism: Citrate Toxicity

Citrate acts as a calcium chelator present in most red blood cell (RBC) additives and blood components, directly binding to and inactivating circulating calcium ions 1, 2, 3
A standard unit of RBC (300-400 mL) typically contains up to 3 grams of citrate, which represents a substantial calcium-binding load 1, 2, 3
Renal insufficiency impairs citrate clearance, particularly problematic in patients with immature renal function 1, 2, 3

Hypoperfusion and hypothermia both impair citrate metabolism, worsening calcium chelation 4, 5
Large volume transfusions are particularly associated with hypocalcemia, especially during massive transfusion protocols 1, 2, 3
Fresh frozen plasma (FFP) and platelet products contain particularly high citrate concentrations 5

Critical hypocalcemia (<0.8 mmol/L) carries particular risk for cardiac dysrhythmias 4, 5
Hypocalcemia causes coagulopathy with platelet dysfunction and decreased clot strength 4, 5
Cardiovascular dysfunction including impaired myocardial contractility and dysrhythmias 4, 5
In patients, severe hypocalcemia can cause neuromuscular excitability and seizures, though this is rare 1, 2, 3

Measure ionized calcium at baseline and every 1-4 hours during massive transfusion, or every 4-6 hours during intermittent transfusions 4
Target maintaining ionized calcium >0.9 mmol/L to support cardiovascular function and coagulation 4, 5
Normal ionized calcium range is 1.1-1.3 mmol/L (pH-dependent) 4, 5
The American College of Critical Care recommends 1 gram of calcium chloride per liter of citrated blood products transfused 4
Calcium chloride 10% contains 270 mg elemental calcium per 10 mL, compared to only 90 mg in calcium gluconate 10% 4, 5
Colloid infusions (but not crystalloids) can independently contribute to hypocalcemia 4, 5
Correction of acidosis may paradoxically worsen hypocalcemia, as acidosis increases ionized calcium levels 5
In patients, pre-existing hypocalcemia is common and can be aggravated by transfusion, leading to high calcium requirements 1, 2, 3
Standard coagulation laboratory tests may not reflect the true impact of hypocalcemia on coagulation, as blood samples are citrated then recalcified before analysis 5

The American College of Critical Care recommends administering calcium chloride (preferred) or calcium gluconate during massive transfusion when ionized calcium falls below 0.9 mmol/L, monitoring levels every 1-4 hours, with particular vigilance when transfusing more than 4-6 units of blood products 6
Target ionized calcium >0.9 mmol/L to support cardiovascular function and coagulation (normal range: 1.1-1.3 mmol/L) 6
Massive transfusion protocols (>10 units in 24 hours or ongoing rapid transfusion) require aggressive monitoring of ionized calcium levels 6
Rapid transfusion rates using pressure devices or rapid infusion systems increase the risk of hypocalcemia 7
FFP and platelet transfusions, which contain particularly high citrate concentrations (up to 3 grams per unit), require close monitoring of ionized calcium levels 6

Hypocalcemia occurs in approximately 70% of patients receiving large volume transfusions, leading to coagulopathy, impaired platelet function, and decreased clot strength 6
Cardiovascular dysfunction, including reduced myocardial contractility and systemic vascular resistance, can occur due to hypocalcemia 6
Low calcium at admission is associated with increased mortality in trauma patients, making aggressive correction during massive transfusion protocols crucial 6
The American Academy of Pediatrics recommends using calcium chloride 10% as first-line therapy, providing 270 mg elemental calcium per 10 mL, administered at 20 mg/kg (0.2 mL/kg of 10% solution) by slow IV push during cardiac arrest, or infuse over 30-60 minutes for other indications 8

Trauma patients with hypocalcemia at hospital admission require aggressive correction during massive transfusion protocols to predict mortality 6
Patients with traumatic brain injury require maintenance of platelet count >100 × 10⁹/L, necessitating more aggressive calcium supplementation to support platelet function 9

The American Society of Anesthesiologists recommends that citrate is used as the anticoagulant in all standard blood components, including whole blood, packed red blood cells, fresh frozen plasma, and platelets 10
Citrate-phosphate-dextrose (CPD) and its variants are effective anticoagulants for blood component preparation, as stated by the Journal of Thrombosis and Haemostasis 11
Trisodium citrate at 0.109 M final concentration is the most commonly used anticoagulant, according to Circulation Research and the Journal of Thrombosis and Haemostasis 12, 13

The American Society of Anesthesiologists notes that when large volumes of blood products are transfused rapidly, citrate metabolism can be overwhelmed, leading to hypocalcemia, with cardiac manifestations including dysrhythmias and impaired myocardial contractility 10
Citrate toxicity is exacerbated by liver dysfunction, hypothermia, hypoperfusion, and renal insufficiency, as reported by the Anesthesiology society 10